Report cover image

Global Point of Care (PoC) Diagnostics Market: Current Analysis and Forecast (2022-2028)

Publisher UnivDatos Market Insights
Published Jan 01, 2023
Length 152 Pages
SKU # Univ17768306

Description

Global Point of Care (PoC) Diagnostics Market: Current Analysis and Forecast (2022-2028)

Point-of-care testing (POCT) allows physicians to detect and diagnose diseases at or near the patient site, faster than conventional lab-based testing. The rising prevalence of chronic diseases, rapid urbanization, and decentralization of diagnostic centers attributes to the market growth of point-of-care molecular diagnosis. For instance, as per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. Among them, breast cancer accounted for 2.26 million cases and lung 2.21 million cases. Furthermore, increasing awareness about the early detection of infectious disease also attributes to the market growth of point-of-care molecular diagnostics.

Therefore, the increasing prevalence of infectious and rare diseases is expected to drive the global point-of-care diagnosis market at a CAGR of 7%, during the forecast period. Factors such as the growing adoption of advanced and fast diagnostic procedures are also catalyzing the growth of the PoC diagnostic market.
  • Based on the product, the market has been categorized into glucose monitoring kits, infectious disease testing kits, pregnancy & fertility testing kits, hematology testing kits, cardiometabolic monitoring kits, urinalysis testing kits, cholesterol testing strips, drug abuse testing strips, and others. Among them, the infectious disease testing kits segment holds a considerable share of the market. The increasing number of infectious diseases such as pneumonia, typhoid, and tuberculosis, is responsible for the growth of the point-of-care infectious disease kit market. For instance, as per the WHO, Pneumonia accounts for 14% of all deaths of children under 5 years old, killing 740,180 children in 2019.
  • Based on the end-user, the market has been categorized into hospital and critical care settings, ambulatory care settings, research laboratories, and others. Among them, the hospital and critical care settings segment holds a significant market share. The rising demand for urgent care and their requirement in the emergency department is attributed to the rising demand for point-of-care diagnostics from hospitals & critical care settings.
  • For a better understanding of the market adoption of the point-of-care (PoC) diagnostics industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. In 2020, North America is anticipated to hold a considerable market share. The major factors such as the availability of leading market players in the region and new product launches, especially in the United States, are attributing the growth of the point-of-care diagnostics market in the region. For instance, in November 2022, Roche announced plans for the U.S. launch of the cobas® 5800 System, a compact, fully automated molecular laboratory instrument that offers a flexible, PCR testing solution that aids clinicians in the diagnosis of infectious diseases.
  • Some of the major players operating in the market are F. Hoffmann-La Roche Ltd; BD; QIAGEN; Danaher; Quidel Corporation; Siemens Healthcare GmbH; Abbott; BIOMÉRIEUX; Nova Biomedical; and NIPRO.

Table of Contents

152 Pages
1 MARKET INTRODUCTION
1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1. Research Process of the Point of Care (PoC) Diagnostics Market
2.2. Research Methodology of the Point of Care (PoC) Diagnostics Market
2.3. Respondent Profile
3 MARKET SYNOPSIS
4 EXECUTIVE SUMMARY
5 IMPACT OF COVID-19 ON THE POINT OF CARE (POC) DIAGNOSTICS MARKET
6 POINT OF CARE (POC) DIAGNOSTICS MARKET REVENUE (USD BN), 2020-2028F
7 MARKET INSIGHTS BY PRODUCT
7.1. Glucose Monitoring Kits
7.2. Infectious Disease Testing Kits
7.3. Pregnancy and Fertility Testing Kits
7.4. Hematology Testing Kits
7.5. Cardiometabolic Monitoring Kits
7.6. Urinalysis Testing Kits
7.7. Cholesterol Testing Strips
7.8. Drug Abuse Testing Strips
7.9. Others
8 MARKET INSIGHTS BY END-USER
8.1. Hospital and Critical Care Settings
8.2. Ambulatory Care Settings
8.3. Research Laboratories
8.4. Others
9 MARKET INSIGHTS BY REGION
9.1. North America
9.1.1. U.S.
9.1.2. Canada
9.1.3. Rest of North America
9.2. Europe
9.2.1. Germany
9.2.2. U.K.
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of World
10 POINT OF CARE (POC) DIAGNOSTICS MARKET DYNAMICS
10.1. Market Drivers
10.2. Market Challenges
10.3. Impact Analysis
11 POINT OF CARE (POC) DIAGNOSTICS MARKET OPPORTUNITIES
12 POINT OF CARE (POC) DIAGNOSTICS MARKET TRENDS
13 DEMAND AND SUPPLY-SIDE ANALYSIS
13.1. Demand Side Analysis
13.2. Supply Side Analysis
14 VALUE CHAIN ANALYSIS
15 COMPETITIVE SCENARIO
15.1. Competitive Landscape
15.1.1. Porters Fiver Forces Analysis
16 COMPANY PROFILED
16.1. F. Hoffmann-La Roche Ltd
16.2. BD
16.3. QIAGEN
16.4. Danaher
16.5. Quidel Corporation
16.6. Siemens Healthcare GmbH
16.7. Abbott
16.8. BIOMÉRIEUX
16.9. Nova Biomedical
16.10. NIPRO
17 DISCLAIMER

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us